Fletcher Spaght Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Fletcher Spaght Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2018	PhaseBio Pharmaceuticals	$34.0M Series D	—	Vensana Capital, AstraZeneca, Cormorant Asset Management, Clay B. Thorp, Johnson & Johnson Innovation, Mountain Group Partners, New Enterprise Associates, Rock Springs Capital, Syno Capital
Nov 30, 2017	PhaseBio Pharmaceuticals, Inc.	$15.6M Debt / Other Equity	Scott McCarty	AstraZeneca, Hatteras Venture Partners, Johnson & Johnson Innovation, New Enterprise Associates, Syno Capital
Sep 12, 2017	Cheetah Medical	$11.8M Series C	—	HighCape Capital, MVM Partners, Robert Bosch Venture Capital, Springfield Investment Management
Jan 18, 2017	PhaseBio Pharmaceuticals, Inc.	$14.7M Other Equity	—	AstraZeneca, Hatteras Venture Partners, Johnson & Johnson Innovation, Justin Klein, Syno Capital
Sep 3, 2015	HistoSonics	$3.0M Other Equity	—	Early Stage Partners, Grand Angels, Hatteras Venture Partners, TGap Ventures, Venture Investors
Mar 1, 2015	PhaseBio Pharmaceuticals	$40.0M Series C	Michael Gutch	Bain Capital Life Sciences, Hatteras Venture Partners, Johnson & Johnson Innovation, Red Tree Venture Capital, Vensana Capital, James Barrett, Johnson & Johnson Innovation, New Enterprise Associates
Feb 25, 2014	Cheetah Medical	$9.0M Other Equity	Renard Charity	Ascension Ventures, Stephen Reeders, Robert Bosch Venture Capital, Springfield Investment Management
Oct 1, 2013	Swift Biosciences	$7.0M Series B	Peter Kleinhenz	Mercury Fund, Michigan Accelerator Fund, Renaissance Venture Capital Fund
Jul 16, 2012	Juventas Therapeutics	$22.2M Series B	Triathlon Medical Ventures	Early Stage Partners, Glengary, Global Cardiovascular Innovation Center, Reservoir Venture Partners, Takeda Ventures, Tri-State Growth Fund, Venture Investors
Jun 5, 2012	PhaseBio Pharmaceuticals, Inc.	$23.0M Series B Extension	—	Astellas Venture Management, Hatteras Venture Partners, Johnson & Johnson Innovation, New Enterprise Associates
Aug 29, 2011	Metabolon	$13.1M Series D	—	Aurora Funds, Fulcrum Financial Partners, Harris & Harris Group, Tim Keating, Sevin Rosen Funds, Syngenta Ventures
Aug 16, 2011	SironRX Therapeutics	$3.4M Series A	Claiborne ("Clay") Rankin	Cleveland Clinic, Early Stage Partners, Glengary, JumpStart, Ohio Tech Angel Fund, XGen Ventures
Jul 9, 2011	SurgiQuest	$19.0M Other Equity	—	Aphelion, California Technology Ventures, CMEA Capital
Feb 24, 2011	HTG	$15.7M Series D	Peter Bisgaard	Molly Hoult, Merck Research Labs, Solstice Capital, Valley Ventures
Dec 2, 2010	PhaseBio Pharmaceuticals, Inc.	$15.0M Series B	New Enterprise Associates	Hatteras Venture Partners, Johnson & Johnson Innovation, OSI Investment Holdings
Jan 1, 2010	PhaseBio Pharmaceuticals	$25.0M Series B	Justin Klein, OSI Investment Management	Bain Capital Life Sciences, Hatteras Venture Partners, Johnson & Johnson Innovation, Red Tree Venture Capital, Vensana Capital, James Barrett, Johnson & Johnson Innovation